Related Experiment Video
Updated: Sep 9, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Pharmacist-led guideline-directed medical therapy in heart failure: impact analysis in primary care
Markus Schichtel1, Stephen Barclay2, Helena Papworth3
1Department of Public Health and Primary Care, University of Cambridge, Cambridge, England, UK ms2591@cam.ac.uk.
Insights
A pharmacist-led heart failure (HF) management model significantly increased guideline-directed medical therapy (GDMT) rates in primary care. This approach reduced healthcare costs, GP workload, mortality, and hospitalizations, improving patient quality of life.
Area of Science:
- Cardiology and Primary Care Medicine
- Pharmacist-led Health Interventions
- Health Services Research
Background:
- Guideline-directed medical therapy (GDMT) for heart failure (HF) improves outcomes but is underused in UK primary care.
- Limited GP capacity and increasing HF burden necessitate innovative care models.
- Suboptimal GDMT contributes to preventable mortality and hospital admissions.
Purpose of the Study:
- To evaluate a novel pharmacist-led GDMT model for optimizing HF care in UK primary care.
- To assess the impact on GDMT rates, healthcare costs, GP workload, mortality, and quality of life.
Main Methods:
- A multisite, quantitative impact analysis involving 237 low-risk HF patients.
- Utilized the HF Event STrengthening Score for patient identification.
- Compared optimal GDMT rates, costs, and workload at baseline, 6 months, and 2 years.
Main Results:
- Optimal GDMT increased from 17.7% at baseline to 76.5% at 6 months and 94.5% at 2 years.
- Reduced GP workload by 36.6% (6 months) and 42.1% (2 years); healthcare costs by 18.4% (6 months) and 20.3% (2 years).
- Subgroup analysis showed reduced cardiovascular mortality (20.8%), hospitalizations (34.8%), and improved quality of life (5.31 KCQ score).
Conclusions:
- Pharmacist-led GDMT optimization significantly improves treatment rates for low-risk HF patients.
- This model effectively reduces healthcare costs and GP workload.
- The approach shows potential for widespread implementation to improve HF patient outcomes and manage workload pressures.
Abstract:
Optimal guideline-directed medical therapy (GDMT) can reduce mortality, unplanned hospital admissions and improve quality of life for patients suffering from heart failure (HF). However, GDMT remains underused in primary care. Only a minority of patients on HF registers receive optimal GDMT in the UK. This suboptimal care is compounded by a mounting lack of GP capacity and the growing burden of HF.A multisite, quantitative impact analysis was undertaken to evaluate the optimisation of HF patients by a novel pharmacist-led GDMT model in UK primary care.We identified low-risk HF patients suitable for pharmacists' input, including a community validated risk stratification tool-the HF Event STrengthening Score. The primary outcome was to compare the proportion of patients on optimal HF GDMT at 6 months and 2 years with baseline. Secondary outcomes were direct personnel healthcare costs and GP workload. A subgroup analysis was modelled to estimate effect on mortality, hospitalisation and quality of life.A total of 237 patients were included. Pharmacist-led GDMT contributed to the increase of optimal GDMT from 17.7% at baseline to 76.5% at 6 months and 94.5% at 2 years follow-up. The novel approach reduced GPs' HF GDMT workload by 36.6% at 6 months and 42.1% at 2 years and healthcare costs by 18.4% at 6 months and 20.3% at 2 years. Patients with combined angiotensin receptor neprilysin inhibitor/sodium glucose co-transporter 2 inhibitor treatment indicated a reduction of 20.8% in cardiovascular mortality, a reduction of 34.8% in hospitalisations and a 5.31 Kansas City Cardiomyopathy Questionnaire Score for improved quality of life at 2 years.For low-risk HF patients, pharmacist-led optimisation achieved significantly higher GDMT rates, reduced personnel healthcare costs, reduced GPs' workload, contributed to reduced cardiovascular mortality, reduced hospitalisations and improved quality of life. In the context of current workload pressures, this approach should be considered for widespread implementation in general practice.
More Related Videos
Related Concept Videos
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Rheumatic Heart Disease III: Medical Management
Heart Failure VII: Nursing Interventions
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

